Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11257 - 11264 of 12008 results
The FTC Fires Back Against Wyndham
November 2, 2012| Blog| Viewpoint
Google and Rosetta Stone Settle AdWords Trademark Infringement Suit
October 31, 2012| Blog| Viewpoint
Section 409A Document Correction Relief: Take the Final Bite of the Apple before December 31st
October 30, 2012| Blog| Viewpoint
Second Circuit Applies the Filed Rate Doctrine to Electricity Rates Set by Market-Based Auctions
October 29, 2012| Blog| Viewpoint
EEOC Publishes Fact Sheet Describing the Application of Anti-Discrimination Laws to Victims of Gender-Based Violence
October 29, 2012| Blog| Viewpoint
Barnes & Noble PIN Pad Devices Hit By Hackers
October 25, 2012| Blog| Viewpoint
Congratulations to Geri Haight, Winner of INTA's 2012 Volunteer Service Award
October 22, 2012| Blog| Viewpoint
House Committee Moving Forward with Subpoena Regarding Medicare Advantage Demonstration Project
October 22, 2012| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|